Calyxt 

$6.3
42
-$23.55-78.89% Wednesday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
307.7M
P/E Ratio
-0.37
Dividend Yield
-
Dividend
-

Earnings

2AugExpected
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-1.09
-0.73
-0.38
-0.02
Expected EPS
-0.02
Actual EPS
N/A

Financials

-10,758.6%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
157,000Revenue
-16.89MNet Income

Analyst Ratings

$9.00Average Price Target
The highest estimate is 15.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CLXT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is involved in gene editing, a technology that can be applied in agriculture to develop crops with desirable traits, similar to Cibus's gene editing platform for crop improvement.
Editas Medicine
EDIT
Mkt Cap276.95M
Editas Medicine operates in the gene editing space using CRISPR technology, which can be applied to agriculture, making it a competitor in the development of genetically modified crops.
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Intellia Therapeutics is another company working with CRISPR technology for gene editing, which has applications in agriculture for crop improvement, competing with Cibus's offerings.
Evogene
EVGN
Mkt Cap11.24M
Evogene is a biotechnology company that uses computational biology to improve crop productivity and biofuel production, directly competing with Cibus in the agricultural biotech sector.
Corteva
CTVA
Mkt Cap41.72B
Corteva Agriscience is focused on providing agricultural products including seeds and crop protection, directly competing with Cibus in the aim to improve crop yields and resilience.
SYLA Technologies. American Depositary Shares
SYT
Mkt Cap60.16M
Syngenta is a major player in the agribusiness, focusing on agrochemicals and seeds, competing with Cibus in the development of improved crops through biotechnology.
Dow
DOW
Mkt Cap16.95B
DowDuPont, now split into DuPont and Dow, was involved in agricultural sciences and biotechnology, competing with Cibus in the development of advanced agricultural products.

About

Commercial Services
Miscellaneous Commercial Services
Agriculture, Forestry, Fishing and Hunting
All Other Grain Farming
Calyxt, Inc. is technology company, which engages in delivering plant-based solutions. The company is headquartered in Roseville, Minnesota and currently employs 50 full-time employees. The firm is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The firm also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics. The firm products include Consumer Centric and Farmer Centric products. Consumer Centric product, which includes high oleic soybean, high fiber wheat, high fiber wheat II, reduced gluten wheat, cold storable potato and reduced browning potato. Farmer Centric products, which includes drought tolerant soybean, improved soybean, herbicide tolerant wheat, herbicide tolerant canola, herbicide tolerant alfalfa and herbicide quality alfalfa.The Company has several products under development including high oleic soybeans, powdery mildew resistant wheat and cold storable potato.
Show more...
CEO
Employees
59
Country
US
ISIN
US13173L1070

Listings

0 Comments

Share your thoughts

FAQ

What is Calyxt stock price today?
The current price of CLXT is $6.3 USD — it has decreased by -78.89% in the past 24 hours. Watch Calyxt stock price performance more closely on the chart.
What is Calyxt stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Calyxt stocks are traded under the ticker CLXT.
What is Calyxt market cap?
Today Calyxt has the market capitalization of 307.7M
What is Calyxt revenue for the last year?
Calyxt revenue for the last year amounts to 157,000 USD.
What is Calyxt net income for the last year?
CLXT net income for the last year is -16.89M USD.
How many employees does Calyxt have?
As of April 02, 2026, the company has 59 employees.
In which sector is Calyxt located?
Calyxt operates in the Basic Materials sector.
When did Calyxt complete a stock split?
The last stock split for Calyxt was on June 01, 2023 with a ratio of 1:5.